Search - tctmd.com

Displaying 521 - 540 of 682

Sort: Relevancy | Date

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

News Conference News ACC 2015

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

L.A. McKeown

March 15, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

News Daily News

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

L.A. McKeown

February 26, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

L.A. McKeown

January 12, 2015

News Daily News

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Todd Neale

December 22, 2014

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Salynn Boyles

December 11, 2014

Presentation

Hybrid Revascularization for Multivessel CAD

Presenter: M Gasior

November 25, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

News Daily News

Heart Block Itself Does Not Worsen Prognosis After AMI

Caitlin E. Cox

October 10, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation ESC 2014

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Presenter: Thomas Pilgrim

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

Advertisement

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

DES With Biodegradable Polymer Safe, Durable Through 5 Years

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Hybrid Revascularization for Multivessel CAD

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

Heart Block Itself Does Not Worsen Prognosis After AMI

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content